Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002574.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 32.17 1.48 1.12
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -8.49 8.25 -9.02
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 7.12 6.09 5.68
Cash -2.75 3.12 3.21
Capex -170.94 -1.73 -0.64
Free Cash Flow 88.80 -2.05 1.09
Revenue 101.40 2.64 1.31
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -38.67 0.10 0.17
Operating Margin -57.94 0.02 0.04
ROA -60.59 < 0.005 < 0.005
ROE -58.24 < 0.005 0.02
ROIC -43.87 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002574.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002574.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002574.SZ is permitted for members.